Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr-Jun;27(2):390-395.
doi: 10.4103/jomfp.jomfp_46_23. Epub 2023 Jul 13.

Gene therapy as a treatment of oral cancer: An insight

Baishakhi Modak  1 , Monica C Solomon  1 , Shaswata Karmakar  2 , Shreyasi Polley  1
Affiliations
Review

Gene therapy as a treatment of oral cancer: An insight

Baishakhi Modak et al. J Oral Maxillofac Pathol. 2023 Apr-Jun.

Abstract

Oral cancer or oral squamous cell carcinoma comprises more than three-fourth of all the malignant neoplasms of the oral cavity. Worldwide, it is the 18th most common malignancy. The patients suffering from cancer usually remains immune to the standard therapies such as surgical resection of tumours, radiotherapy and chemotherapy; however, there can be probabilities of chronic and acute toxicities and secondary malignancies as well. Recently, gene therapy has been introduced in the arena of biomedicine to improve the treatment modality for oral malignant and potentially malignant disorders. It replaces the defective gene followed by repairing by a therapeutic gene. Gene therapy can attack cancerous cells without causing harmful effect to the normal tissue. It is useful to cope with the relapse of diseases and as a synergetic treatment. The present article reviewed the types of gene therapy, modes of delivery of the therapeutic genes and different techniques used along with pros and cons of gene therapy.

Keywords: Gene therapy; nanoparticles; oral squamous cell carcinoma (OSCC).

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Sudbø J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer. 2005;115:339–45. - PubMed
    1. Chaudhary N, Gupta DK, Verma RK, Choudhary SR. Squamous cell carcinoma of tongue in a 12- year-old child. Acta Otolaryngol Case Rep. 2016;1:87–9.
    1. Leão ML, Sant'Ana MS, Mesquita RA, Gomez RS, Santos Silva AR, Khurram SA, et al. Oral squamous cell carcinoma frequency in young patients from referral centers around the world. Head Neck Pathol. 2022;16:755–62. - PMC - PubMed
    1. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people-A comprehensive literature review. Oral Oncol. 2001;37:401–18. - PubMed
    1. Sunil PM, Joseph I, Varghese SS. Gene therapy in oral squamous cell carcinoma – A short review. Oral Maxillofac Pathol J. 2011;2:142–7.